Existing technologies enable isolating antigen-specific monoclonal antibodies (mAbs) from B cells. mAbs targeting the conformational V3 loop crown of HIV Env; the new mAbs cross-neutralized viruses of different clades. The novel technology allows isolating mAbs from RMs or other hosts given experimental immunogens or infectious agents. Introduction Isolation of naturally induced and matured antibodies (Abs)… Continue reading Existing technologies enable isolating antigen-specific monoclonal antibodies (mAbs) from B cells.